Matches 1 - 50 out of 145 1 2 3 >
Match Document Document Title
7550491 Ionic liquids having [N(CF3)2]anions  
The present invention relates to salts comprising bis(trifluoromethyl)imide anions and saturated, partially or fully unsaturated, heterocyclic cations, to a process for the preparation thereof, and...
7547444 Methods for controlling fungi and bacteria  
The present invention includes compounds of pyridinium salts and methods of their use for agricultural purposes. The present invention also relates to methods of controlling fungi and/or bacteria.
7541045 Concentrated, non-foaming solution of quaternary ammonium compounds and methods of use  
A concentrated quaternary ammonium compound (QAC) solution comprising a QAC with a concentration from greater than about 10% by weight and at least one solubility enhancing agent, such as an...
7456197 Pyridinium cationic lipids as gene transfer agents  
Pyridinium cationic lipids useful as non-viral gene delivery agents are disclosed. The agents are prepared by reaction of pyrylium salts with primary amines. Also disclosed are methods of...
7300948 Alkynyl compounds as non nucleoside reverse transcriptase inhibitors  
Inhibitors of HIV reverse transcriptase which are useful for the treatment of HIV infection. Exemplars of the invention are compounds of the formula wherein the substituents are as defined in...
7250428 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it  
Cetylpyridinium salt of diclofenac.
7235576 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors  
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
7189383 Radioactively labelled amino acid analogues, their preparation and use  
The present invention relates to Halogenated amino acid analogues for use in diagnosis, which compounds have the general formula (I) wherein: R is (C 1 –C 6 ) alkyl optionally substituted with...
7141590 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides  
Disclosed are nicotinanilide-N-oxide compounds, methods for their production, pharmaceutical compositions which include these compounds, and methods for their use in various therapies.
7064139 Method for treating retroviral infections  
Compositions and methods of treating a retroviral infection in an afflicted host and/or inhibiting replication of a retrovirus involve administering a therapeutically effective amount of the...
7015239 Fungicide for plants  
A fungicidal composition and method of treating plant diseases using a compound of formula
6984645 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein  
Compounds that are dual aP2/k-FABP inhibitors are provided having the formula wherein A, B, X, Y, R 1 , R 2 and R 3 are as described herein. A method is also provided for treating diabetes...
6953811 N-substituted tetrahydropyridines and their use as pesticides  
A description is given of compounds of the formula in which R 1 and R 2 independently of one another are halogen, C 1 -C 6 alkyl, halo-C 1 -C 6 alkyl, C 1 -C 6 alkoxy, halo-C 1 -C 6 alkoxy,...
6903118 Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides  
The invention relates to new piperazinyl-substituted pyridylalkane, alkene, and alkine acid amides substituted with saturated or one or several-fold unsaturated hydrocarbon residue in the...
6878730 Quaternary ammonium compounds  
The invention features quaternary ammonium compounds of formula I, described herein, and their use in treating asthma, chronic obstructive pulmonary disorder, allergic rhinitis, and infectious...
6864269 Concentrated, non-foaming solution of quarternary ammonium compounds and methods of use  
A concentrated quaternary ammonium compound (QAC) solution comprising a QAC with a concentration from greater than about 10% by weight and at least one solubility enhancing agent, such as an...
6858623 Compounds useful as reversible inhibitors of cysteine proteases  
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formula (Ia) and (Ib) where R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , Het and X are defined herein. The...
6815458 Azacyclic compounds  
Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a...
6784194 Therapeutic use of a thienylcyclohexylamine derivative  
A method of inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals comprising administering to warm-blooded animals before exposure to said products an...
6727237 Inhibitors of bacterial NAD synthetase  
The present invention provides methods of synthesizing and screening inhibitors of bacterial NAD synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections...
6726894 Transport vehicles for macromolecules  
The invention relates to new compounds with the general formula I for use as a tool to introduce macromolecules into cells. The invention further relates to compositions for introducing...
6706741 Acetylcholinesterase inhibitors containing 1-benzyl-pyridinium salts  
The present invention provides an excellent acetylcholinesterase inhibitor. That is, it provides an acetylcholinesterase inhibitor comprising a 1-benzylpyridinium salt represented by the following...
6686358 Bicyclic amino-pyrazinone compounds  
A compound of formula (I): wherein: R 1 represents hydrogen, or linear or branched (C 1 -C 6 )alkyl optionally substituted by one or more identical or different groups selected from aryl,...
6677361 Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia  
Niacin and niacin prodrugs are topically administered as suitable formulations to device for impoving the lipid profiles of subjects, preferably humans.
6664280 Antivesicant compounds and methods of making and using thereof  
As disclosed herein, the present invention provides a compound having the structural formula wherein R 1 , R 2 , R 3 , and R 4 are each independently H, or a methyl, halo, trifluoromethyl,...
6638940 Tetrahydropyridines as pesticides  
Compounds of formula are described, wherein R 1 and R 2 are for example, independently of each other, halogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, halogen-C 1 -C 6 -alkyl, halogen-C 3 -C 6...
6586452 C1 to C4 side chain modified nodulisporic acid analogs  
The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.
6495567 Triaryl methane compounds and their use in the treatment of diarrhea and scours  
A method and product for treating and preventing diarrhea and scours is provided. The method involves treating a subject who has diarrhea, or scours, or is at risk of getting diarrhea or scours...
6469034 Cyclohexenyl-ethyl-thiourea compounds for inhibiting HIV reverse transcriptase  
Novel CycloHexenyl-Ethyl-Thiourea (CHET) compounds as inhibitors of reverse transcriptase and effective agents for the treatment of HIV infection, including mutant, drug-sensitive, drug-resistant,...
6465521 Composition for desorbing bacteria  
The invention provides a composition for desorbing bacteria from solid surfaces and from living tissues, which is in the form of a two-phase preparation, and which upon shaking forms a temporary...
6455555 Anti-HIV infection agents and method for treating HIV infection  
The present invention relates to agents for anti-HIV infection, which contain, as an active ingredient, at least one photosensitizing dye selected from the group consisting of the compounds of the...
6455554 Oxopyridinyl pharmaceutical compositions and methods for use  
Pharmaceutical compositions incorporate aryl substituted olefinic amine compounds. Representative compounds are (2S)-(4E)-N-methyl-5-[3-(5-isopropoxy-1-oxopyridin)yl)]-4-pe nten-2-amine,...
6423698 Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia  
A combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia in susceptible warm-blooded animals which comprises administering a combination of two or more compounds...
6391899 Compounds and compositions for treating tissue ischemia  
There is disclosed a genus of compounds and pharmaceutical compositions that are protective for mitigating damage associated with tissue ischemia, particularly stroke (CNS ischemia), and ischemia...
6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives  
2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives are suitable for the production of pharmaceuticals for the prophylaxis and therapy of diseases or disorders whose course involves increased...
6277360 Washing composition  
The invention provides a washing composition for washing a surface to deposit thereon a solid active agent, the washing composition comprising an emulsion of silicone droplets, the silicone...
6184228 Anti-sickling agents: selection methods and effective compounds  
The present invention is directed to a method for selecting compounds for use in treating sickle cell disease in a patient. The method comprises the steps of selecting a first set of HbS ligands...
6172117 Biocidal preservatives  
Biocidal preservatives for use especially in preventing rotting and deterioration of wood include quaternary ammonium compounds which preferably have a fatty aliphatic substituent on the quaternary...
6162446 In-situ generation of zinc pyrithione in personal care compositions  
Disclosed is a personal care composition comprising: (a) water or an alcohol, (b) at least one dispersant or surfactant, and (c) as an antimicrobial or preservative additive, particles of an...
6090807 Use of heterocyclic compounds  
The present invention relate to the use of heterocyclic compounds of the following formula: Het--A--B--Ar where Het, A, B and Ar have the meanings stated in the description. The compounds...
6028103 Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation  
The present invention provides a class of chemical compounds useful as efficacious drugs in the treatment of sickle cell disease and diseases characterized by unwanted or abnormal cell...
6022551 Antimicrobial composition  
A rapidly acting antimicrobial alcohol-containing composition and method of using the composition to disinfect surfaces, such as the hands is disclosed.
6020333 Compositions containing in particular, riboflavin, for the local prevention of diseases of the genital and rectal mucus membranes  
The invention relates to the field of therapeutic chemistry and concerns novel antiviral pharmaceutical compositions for the local prevention of diseases of the genital and rectal mucus membranes....
5997893 Alcohol based anti-microbial compositions with cosmetic appearance  
The present invention provides antimicrobial compositions containing high levels of alcohol, carbomer polymers and antimicrobial agents. The present invention provides stable, high viscosity...
5981549 Method for controlling or alleviating the symptoms of respiratory disease and allergies  
Disclosed herein is a method for controlling or alleviating the symptoms of respiratory disease and allergies comprising administering to a mammal suffering from respiratory disease or allergies an...
5965621 Methods and compositions for reducing or maintaining body weight in a mammal  
A method for reducing or maintaining the level of adipose tissue formation in a mammal includes the step of administering a pantethine composition to the mammal in an amount and for a period of...
5929096 Method for treating atopic dermatitis and contact dermatitis  
This invention relates to a method of treating atopic and contact dermatitis using compounds of formula (I) ##STR1## wherein the terms A, Z, R, R 1 , R 2 , R 3 and M are herein defined.
5908854 Mycobacterial compositions and methods for their use  
Disclosed are aqueous mycobacterial concentrate compositions at a pH in the range of 6 to 12 which comprises per 100% weight of a concentrate composition: a) from about 0.1% wt. to about 25% wt....
5763482 Biocidal composition and use  
An antimicrobial composition and method for controlling the growth of microbes in an aqueous system is disclosed, the composition comprising an amount, effective for the purpose of a 2-bromo-2-...
5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them  
Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them. There are described compounds of the formula I...
Matches 1 - 50 out of 145 1 2 3 >